Jeparilon 10 chewable tablets
Future Pharma
Future Pharma
Description
Jeparilon is a combination chewable tablet containing Famotidine (10 mg), Calcium Carbonate (800 mg), and Magnesium Hydroxide (165 mg). It is used for the short-term symptomatic relief of heartburn, acid indigestion, hyperacidity, and related digestive discomfort. Its dual action reduces stomach acid and neutralizes it, providing fast and effective relief.
Indications for Use
Short-term symptomatic relief of
Heartburn
Indigestion
Acid indigestion
Hyperacidity
Directions for Use and Dosage
Adults and children ≥16 years of age
Chew one tablet for symptom relief
Do not exceed two tablets in 24 hours
Maximum treatment duration: 6 consecutive days
Do not start another course without consulting a doctor or pharmacist
Method of Administration
For oral use
Chew tablet thoroughly before swallowing
Contraindications
-Hypersensitivity to famotidine, calcium carbonate, magnesium hydroxide, or any excipients
-Cross-sensitivity to other H₂-receptor antagonists
-Moderate to severe renal failure
-Severe hepatic impairment
Precautions
-Consult a physician before use if you
-Are taking other medications
-Suffer from other illnesses
-Have pre-existing hypercalcaemia or hypermagnesaemia
-Seek medical advice before use if
-You are over 50 and experiencing new or changed symptoms
-You experience symptoms such as weight loss, anemia, difficulty swallowing, or chest pain
-Discontinue use and consult a doctor if symptoms persist, worsen, or include severe vomiting, black stools, or choking
Not suitable for individuals with
Fructose intolerance
Glucose-galactose malabsorption
Sucrase-isomaltase deficiency
Lactase insufficiency
Galactosaemia
Side Effects
Blood and lymphatic system disorders
Rare: Leukopenia, Pancytopenia
Immune system disorders
Rare: Anaphylactic reaction, Hypersensitivity
Metabolism and nutrition disorders
Rare: Decreased appetite
Psychiatric disorders
Not known: Nervousness
Nervous system disorders
Common: Headache
Uncommon: Dizziness, Dysgeusia (taste disturbance), Somnolence
Rare: Paraesthesia
Gastrointestinal disorders
Uncommon: Abdominal discomfort, pain, diarrhea, dry mouth, flatulence, nausea, vomiting, oropharyngeal discomfort/pain
Rare: Constipation, upper abdominal pain, abdominal distension, abnormal stools, dyspepsia, eructation (belching), thirst
Hepatobiliary disorders
Rare: Cholestatic jaundice, liver disorders
Skin and subcutaneous tissue disorders
Uncommon: Rash
Rare: Angioedema, Pruritus, Urticaria
Very rare: Alopecia
Musculoskeletal disorders
Rare: Arthralgia
Reproductive system and breast disorders
Rare: Gynecomastia
General disorders and administration site conditions
Uncommon: Asthenia, fatigue
Rare: Malaise
Investigations
Rare: Abnormal liver enzyme levels
Pregnancy and Lactation
Pregnancy
Use only if the expected benefit to the mother outweighs the potential risk to the fetus, as adequate studies in pregnant women are lacking.
Lactation
Famotidine is excreted in human milk. Magnesium salts may also pass into breast milk and potentially cause diarrhea in infants. A decision must be made to discontinue either breastfeeding or therapy, weighing benefits and risks.
Storage Conditions
Store below 30°C in a dry place
Keep out of reach of children
Packaging
Carton box containing 5 blister strips, each with 2 chewable tablets, and an insert leaflet.